← All news
Markets
Protagonist Therapeutics stock rating maintained at Buy by Clear Street
Covered by 1 outlet
All coverage · 3 articles
Investing.com Canada
·Aug 31, 17:56 UTC
Protagonist Therapeutics stock rating maintained at Buy by Clear Street
Investing.com UK
·Aug 31, 17:56 UTC
Protagonist Therapeutics stock rating maintained at Buy by Clear Street
Investing.com News
·Aug 31, 17:55 UTC